CA2419729C - Forme cristalline ii de la clarithromycine - Google Patents

Forme cristalline ii de la clarithromycine Download PDF

Info

Publication number
CA2419729C
CA2419729C CA002419729A CA2419729A CA2419729C CA 2419729 C CA2419729 C CA 2419729C CA 002419729 A CA002419729 A CA 002419729A CA 2419729 A CA2419729 A CA 2419729A CA 2419729 C CA2419729 C CA 2419729C
Authority
CA
Canada
Prior art keywords
methylerythromycin
solvent
carbon atoms
prepared
antibiotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002419729A
Other languages
English (en)
Other versions
CA2419729A1 (fr
Inventor
Jih-Hua Liu
David A. Riley
Stephen G. Spanton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BGP Products Operations GmbH
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25680727&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2419729(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/681,723 external-priority patent/US5858986A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to CA002471102A priority Critical patent/CA2471102C/fr
Priority to CA002488397A priority patent/CA2488397C/fr
Publication of CA2419729A1 publication Critical patent/CA2419729A1/fr
Application granted granted Critical
Publication of CA2419729C publication Critical patent/CA2419729C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La présente invention concerne le nouvel antibiotique 6-O-méthylérythromycine A sous formes cristallines I et II. Ces composés ont une activité antibiotique.
CA002419729A 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine Expired - Lifetime CA2419729C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA002471102A CA2471102C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine
CA002488397A CA2488397C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/681,723 1996-07-29
US08/681,723 US5858986A (en) 1996-07-29 1996-07-29 Crystal form I of clarithromycin
CA002258606A CA2258606C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002258606A Division CA2258606C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CA002488397A Division CA2488397C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine
CA002471102A Division CA2471102C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Publications (2)

Publication Number Publication Date
CA2419729A1 CA2419729A1 (fr) 1998-02-05
CA2419729C true CA2419729C (fr) 2005-02-01

Family

ID=25680727

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002386527A Expired - Lifetime CA2386527C (fr) 1996-07-29 1997-07-25 Forme cristalline i de la clarithromycine
CA002419729A Expired - Lifetime CA2419729C (fr) 1996-07-29 1997-07-25 Forme cristalline ii de la clarithromycine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002386527A Expired - Lifetime CA2386527C (fr) 1996-07-29 1997-07-25 Forme cristalline i de la clarithromycine

Country Status (1)

Country Link
CA (2) CA2386527C (fr)

Also Published As

Publication number Publication date
CA2386527C (fr) 2003-05-27
CA2419729A1 (fr) 1998-02-05
CA2386527A1 (fr) 1998-02-05

Similar Documents

Publication Publication Date Title
EP0915898B1 (fr) Forme cristalline i de la clarithromycine
CA2309963C (fr) Oxime de 6-o-alkyle erythromycine b
AU2001222619C1 (en) Processes for preparing clarithromycin polymorphs
US6680299B2 (en) 4'-substituted leucomycins
AU783055B2 (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV
CA2419729C (fr) Forme cristalline ii de la clarithromycine
CA2488397C (fr) Forme cristalline ii de la clarithromycine
CA2386534C (fr) Forme cristalline ii de la clarithromycine et son utilite
AU777612B2 (en) Crystal form I of clarithromycin
CN101812102B (zh) 6-o-甲基红霉素a晶型v
MXPA00005405A (en) 6-o-alkyl erythromycin b oxime
ZA200204638B (en) Processes for preparing clarithromycin polymorphs and novel polymorph IV.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170725